Developing Content for an Interprofessional Training on Fear of Cancer Recurrence (FCR): Key Informant Interviews of Healthcare Professionals, Researchers and Cancer Survivors
Document Type
Article
Publication Date
4-10-2018
Abstract
Background: Growing numbers of cancer survivors are receiving healthcare through primary care practitioners, who often lack cancer-specific expertise to effectively treat survivors’ concerns. Addressing that gap, this study aimed to develop content for a training on fear of cancer recurrence (FCR), a common concern in survivorship. Methods: Grounded in naturalistic inquiry, 42 key-informant interviews were conducted, transcribed, and analyzed for themes. Participants were healthcare professionals, researchers, and cancer survivors Results: Results included themes ranging from: rich conceptualizations of FCR, opportunities and challenges for addressing FCR in healthcare settings, interventions to address FCR, and important information to include in a training on FCR. Conclusions: This paper provides content for an interprofessional training and highlights the importance of developing trainings for interprofessional teams, given identified barriers that physicians face in addressing FCR and other psychosocial concerns of survivors in primary care.
Publication Title
Journal of Psychosocial Oncology
Repository Citation
Berrett-Abebe, Julie; Cadet, Tamara; Vitello, Joan; and Maramaldi, Peter, "Developing Content for an Interprofessional Training on Fear of Cancer Recurrence (FCR): Key Informant Interviews of Healthcare Professionals, Researchers and Cancer Survivors" (2018). School of Education and Human Development Faculty Publications. 187.
https://digitalcommons.fairfield.edu/education-facultypubs/187
Published Citation
Julie Berrett-Abebe, Tamara Cadet, Joan Vitello & Peter Maramaldi (2018) Developing content for an interprofessional training on fear of cancer recurrence (FCR): Key informant interviews of healthcare professionals, researchers and cancer survivors, Journal of Psychosocial Oncology, 36:3, 259-273, DOI: 10.1080/07347332.2018.1443987
DOI
10.1080/07347332.2018.1443987
Peer Reviewed
Comments
© 2018 Taylor & Francis Group, LLC. All rights reserved.
A link to full text has been provided for authorized subscribers.